Professors Marcus Maurer and Luis Felipe Ensina deliberate on the most recent findings that emerged at The American Academy of Allergy, Asthma & Immunology (AAAAI) conference held in San Antonio, Texas. In particular, Professor Maurer discusses poster presentations concerning the efficacious use of omalizumab and dupilumab for the management of urticaria. Professor Ensina expands the discussion by outlining ongoing projects and upcoming projects within UCARE that will be presented at the forthcoming UCARE conference in São Paulo in 2023.
Access additional resources by signing up to Medthority and to be notified for future 'All Things Urticaria' podcast episodes! 
Do you have suggestions for future episodes? Please visit UCARE to provide feedback via the link here and offer your suggestions for future topics and expert selection!

Professors Marcus Maurer and Luis Felipe Ensina deliberate on the most recent findings that emerged at The American Academy of Allergy, Asthma & Immunology (AAAAI) conference held in San Antonio, Texas. In particular, Professor Maurer discusses poster presentations concerning the efficacious use of omalizumab and dupilumab for the management of urticaria. Professor Ensina expands the discussion by outlining ongoing projects and upcoming projects within UCARE that will be presented at the forthcoming UCARE conference in São Paulo in 2023. Access additional resources by signing up to Medthority and to be notified for future 'All Things Urticaria' podcast episodes! Do you have suggestions for future episodes? Please visit UCARE to provide feedback via the link here and offer your suggestions for future topics and expert selection!

Professors Marcus Maurer and Luis Felipe Ensina deliberate on the most recent findings that emerged at The American Academy of Allergy, Asthma &amp; Immunology (AAAAI) conference held in San Antonio, Texas. In particular, Professor Maurer discusses poster presentations concerning the efficacious use of omalizumab and dupilumab for the management of urticaria. Professor Ensina expands the discussion by outlining ongoing projects and upcoming projects within UCARE that will be presented at the forthcoming UCARE conference in São Paulo in 2023.
Access additional resources by signing up to Medthority and to be notified for future 'All Things Urticaria' podcast episodes!&nbsp;
Do you have suggestions for future episodes? Please visit UCARE to provide feedback via the link here&nbsp;and offer your suggestions for future topics and expert selection!

Episode 60 - Updates from AAAAI Conference 2023

Catch up on ’All Things Urticaria’ in this podcast series developed by Global Allergy and Asthma Excellence Network UCARE in collaboration with Medthority. Professor Marcus Maurer, Professor of Dermatology and Allergy at Charité – Universitätsmedizin Berlin, is joined by colleagues for in-depth discussions on the latest research and opinion on the pathogenesis and treatment of urticaria. Medthority received educational funding from the sponsor to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated content. The opinions in this podcast are of the invited faculty, for informational purposes only, and should not be taken as medical advice. Please consult your regional guidelines for clinical practice recommendations in your area. For updates on ’All Things Urticaria’, sign up on Medthority. For more on UCARE/ACARE activities, visit the UCARE and ACARE websites, UCARE 4U, UDAY, CRUSE Control App, and CURE Registry.

Episodes 1 – 61: This content has been developed independently of the sponsor, Novartis Pharma AG. 
Episode 31 and 33: This content has been in collaboration with J. Uriach y Compañía S.A.

Science

Catch up on ’All Things Urticaria’ in this podcast series developed by Global Allergy and Asthma Excellence Network UCARE in collaboration with Medthority. Professor Marcus Maurer, Professor of Dermatology and Allergy at Charité – Universitätsmedizin Berlin, is joined by colleagues for in-depth discussions on the latest research and opinion on the pathogenesis and treatment of urticaria. Medthority received educational funding from the sponsor to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated content. The opinions in this podcast are of the invited faculty, for informational purposes only, and should not be taken as medical advice. Please consult your regional guidelines for clinical practice recommendations in your area. For updates on ’All Things Urticaria’, sign up on Medthority. For more on UCARE/ACARE activities, visit the UCARE and ACARE websites, UCARE 4U, UDAY, CRUSE Control App, and CURE Registry. Episodes 1 – 61: This content has been developed independently of the sponsor, Novartis Pharma AG. Episode 31 and 33: This content has been in collaboration with J. Uriach y Compañía S.A.

Share Episode 60 - Updates from AAAAI Conference 2023

Sign up to save your podcasts

Episode 60 - Updates from AAAAI Conference 2023

Episode 60 - Updates from AAAAI Conference 2023

More shows like All Things Urticaria

Dr. Ruscio Radio, DC: Health, Nutrition and Functional Healthcare

White Coat, Black Art

Pod Save America

The Daily

Les grands dossiers de l'Histoire par Franck Ferrand

Front Burner

The Healthy Skin Show

L'œil de Philippe Caverivière

Entrez dans l'Histoire